Skip to main content Accessibility help

Developing an international scoring system for a consensus-based social cognition measure: MSCEIT-managing emotions

  • G. S. Hellemann (a1) (a2), M. F. Green (a1) (a2) (a3), R. S. Kern (a1) (a2) (a3), G. Sitarenios (a4) and K. H. Nuechterlein (a1) (a5)...



Measures of social cognition are increasingly being applied to psychopathology, including studies of schizophrenia and other psychotic disorders. Tests of social cognition present unique challenges for international adaptations. The Mayer–Salovey–Caruso Emotional Intelligence Test, Managing Emotions Branch (MSCEIT-ME) is a commonly-used social cognition test that involves the evaluation of social scenarios presented in vignettes.


This paper presents evaluations of translations of this test in six different languages based on representative samples from the relevant countries. The goal was to identify items from the MSCEIT-ME that show different response patterns across countries using indices of discrepancy and content validity criteria. An international version of the MSCEIT-ME scoring was developed that excludes items that showed undesirable properties across countries.


We then confirmed that this new version had better performance (i.e. less discrepancy across regions) in international samples than the version based on the original norms. Additionally, it provides scores that are comparable to ratings based on local norms.


This paper shows that it is possible to adapt complex social cognitive tasks so they can provide valid data across different cultural contexts.


Corresponding author

*Address for corresponding author: M. F. Green, Ph.D., UCLA Semel Institute for Neuroscience and Human Behavior, 760 Westwood Plaza, 27-462, Los Angeles, California 90095, USA. (Email:


Hide All
Buchanan, RW, Davis, M, Goff, D, Green, MF, Keefe, RSE, Leon, AC, Nuechterlein, KH, Laughren, T, Levin, R, Stover, E, Fenton, W, Marder, SR (2005). A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophrenia Bulletin 31, 519.
Davis, MC, Lee, J, Horan, WP, Clarke, AD, McGee, MR, Green, MF, Marder, SR (2013). Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophrenia Research 147, 393397.
Fett, AK, Viechtbauer, W, Dominguez, MD, Penn, DL, van Os, J, Krabbendam, L (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neuroscience and Biobehavioral Reviews 35, 573588.
Fischer-Shofty, M, Brune, M, Ebert, A, Shefet, D, Levkovitz, Y, Shamay-Tsoory, SG (2013). Improving social perception in schizophrenia: the role of oxytocin. Schizophrenia Research 146, 357362.
Green, MF, Harris, JG, Nuechterlein, KH (2014). The MATRICS consensus cognitive battery: what we know 6 years later. American Journal of Psychiatry 171, 11511154.
Green, MF, Nuechterlein, KH, Gold, JM, Barch, DM, Cohen, J, Essock, S, Fenton, WS, Frese, F, Goldberg, TE, Heaton, RK, Keefe, RSE, Kern, RS, Kraemer, H, Stover, E, Weinberger, DR, Zalcman, S, Marder, SR (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry 56, 301307.
Hambleton, RK, Merenda, PF, Spielberger, CD (2005). Adapting Educational and Psychological Tests for Cross-cultural Assessment. Lawrence Erlbaum: Mahwah, NJ.
Harvey, PD, Penn, DL (2010). Social cognition: The key factor predicting social outcome in people with schizophrenia? Psychiatry 7, 4144.
Horan, WP, Kern, RS, Tripp, C, Hellemann, G, Wynn, JK, Bell, M, Marder, SR, Green, MF (2011). Efficacy and specificity of social cognitive skills training for outpatients with psychotic disorders. Journal of Psychiatric Research 45, 11131122.
Kern, RS, Nuechterlein, KH, Green, MF, Baade, LE, Fenton, WS, Gold, JM, Keefe, RSE, Mesholam-Gately, R, Mintz, J, Seidman, LJ, Stover, E, Marder, SR (2008). The MATRICS Consensus Cognitive Battery. Part 2. Co-norming and standardization. American Journal of Psychiatry 165, 214220.
Marder, SR, Fenton, WS (2004). Measurement and treatment research to improve cognition in schizophrenia: NIMH MATRICS Initiative to support the development of agents for improving cognition in schizophrenia. Schizophrenia Research 72, 510.
Mayer, JD, Salovey, P, Caruso, DR (2002). Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) User's Manual. MHS Publishers: Toronto.
Nuechterlein, KH, Green, MF (2006). MATRICS Consensus Cognitive Battery. MATRICS Assessment, Inc.: Los Angeles.
Nuechterlein, KH, Green, MF, Kern, RS, Baade, LE, Barch, D, Cohen, J, Essock, S, Fenton, WS, Frese, FJ, Gold, JM, Goldberg, T, Heaton, R, Keefe, RSE, Kraemer, H, Mesholam-Gately, R, Seidman, LJ, Stover, E, Weinberger, D, Young, AS, Zalcman, S, Marder, SR (2008). The MATRICS Consensus Cognitive Battery. Part 1. Test selection, reliability, and validity. American Journal of Psychiatry 165, 203213.
Pedersen, CA, Gibson, CM, Rau, SW, Salimi, K, Smedley, KL, Casey, RL, Leserman, J, Jarskog, LF, Penn, DL (2011). Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophrenia Research 132, 5053.
Pinkham, AE, Penn, DL, Green, MF, Harvey, PD (2016). Social cognition psychometric evaluation: results of the initial psychometric study. Schizophrenia Bulletin 42, 494504.
Roberts, DL, Penn, DL (2009). Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study. Psychiatry Research 166, 141147.
Velligan, DI, Rubin, M, Fredrick, MM, Mintz, J, Nuechterlein, KH, Schooler, NR, Jaeger, J, Peters, NM, Buller, R, Marder, SR, Dube, S (2012). The cultural adaptability of intermediate measures of functional outcome in schizophrenia. Schizophrenia Bulletin 38, 630641.
Wolwer, W, Frommann, N, Haufmann, S, Piaszek, A, Streit, M, Gaebel, W (2005). Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program. Schizophrenia Research 80, 295303.


Type Description Title
Supplementary materials

Hellemann supplementary material
Hellemann supplementary material 1

 Word (54 KB)
54 KB
Supplementary materials

Hellemann supplementary material
Hellemann supplementary material 2

 Word (16 KB)
16 KB


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed